Moreover, p53 protein expression (indicator of the onset of apoptosis and/or cell adaptive cell responses) was significantly increased (p < 0.05, day 28 after the first tumor therapy) in response to the combinatorial treatment (5FU-MNP and MH) compared to the either therapies alone. The gene discussed is TP53; the disease is neoplasm.